Mylan Is One Of The Largest Players In The Pegfilgrastim Biosimilars Market, According To The Business Research Company’s Pegfilgrastim Biosimilars Global Market Report 2020-30: Covid 19 Growth And Change
(Companies Covered: Mylan, Biocon, Mundipharma, Pfizer, Sandoz, Coherus, Intas Pharmaceuticals, Fresenius Kabi.)
The global pegfilgrastim biosimilar market is expected to decline from $534.43 million in 2019 to $453.11 million in 2020 at a compound annual growth rate of -15.22%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $1,158.72 million in 2023 at a compound annual growth rate of 36.75%.
Read More On The Global Pegfilgrastim Biosimilars Market Report At – https://www.thebusinessresearchcompany.com/report/pegfilgrastim-biosimilars-global-market-report-2020-30-covid-19-growth-and-change
The pegfilgrastim biosimilars market consists of the sales of pegfilgrastim biosimilars and related services offered by the companies that develop and manufacture them. Pegfilgrastim is a version of filgrastim (Neupogen) and is used to increase the production of infection-fighting white blood cells for the treatment of cancer patients undergoing chemotherapy. Pegfilgrastim biosimilars find their applications in reducing infection for patients undergoing anticancer therapy.
Global Pegfilgrastim Biosimilars Market Segmentation –
1) By Application: Chemotherapy Treatment, Transplantation, Others
2) By Distribution Channel: Hospital pharmacies, Retail pharmacies, Mail-Order pharmacies.
Global Pegfilgrastim Biosimilars Market Driver –
Government initiatives for the development of biosimilars are expected to drive the pegfilgrastim biosimilars market. Governments worldwide are focusing on the development of biosimilars due to their cost-effective nature.
Request For A Sample Of The Global Pegfilgrastim Biosimilars Market Report At – https://www.thebusinessresearchcompany.com/sample.aspx?id=3428&type=smp
Few Points From The Global Pegfilgrastim Biosimilars Market TOC
1. Executive Summary
2. Pegfilgrastim Biosimilars Market Characteristics
3. Pegfilgrastim Biosimilars Market Size And Growth
3.1. Global Pegfilgrastim Biosimilars Historic Market, 2015 – 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
4. Pegfilgrastim Biosimilars Market Segmentation
4.1. Global Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5. Pegfilgrastim Biosimilars Market Regional And Country Analysis
5.1. Global Pegfilgrastim Biosimilars Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Pegfilgrastim Biosimilars Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Pegfilgrastim Biosimilars Market
6.1. Asia-Pacific Pegfilgrastim Biosimilars Market Overview
6.2. Asia-Pacific Pegfilgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
State: Greater London
Country: United Kingdom